Temporal Investigation of Multimodal Elements (TIME)

August 12, 2025 updated by: Buck Institute for Research on Aging

An Observational, Longitudinal Study to Characterize the Dynamic Structure of Molecular and Digital Health Data in Healthy Older Adults

The TIME Study is a research project aiming to understand the body's natural rhythms. The goal is to see how daily and weekly changes in our bodies-from what's happening at a molecular level to data from wearable devices-are connected.

What is the study about? This study is trying to create a detailed map of how a person's body changes over time. By looking at information from blood, urine, and other samples, as well as data from smartwatches and other devices, researchers want to learn how our bodies' natural cycles work in healthy older adults. The long-term goal is to use this knowledge to help develop more personalized healthcare in the future.

Who can participate? The study is looking for healthy adults, age 55 or older, who have a smartphone and are able to travel to the Buck Institute in Novato, California, for study visits.

Participants will be asked to:

Attend weekly visits over 11 weeks to provide blood and other samples.

Wear health-tracking devices like a smart ring and watch.

Use a smartphone app to answer questions about their daily routines.

Complete two "challenge" tests, including drinking a glucose solution and exercising on a stationary bicycle.

Return for follow-up visits after 6 and 12 months.

Are there any risks or benefits? Benefits: There are no direct health benefits for participants. However, the information gained will help scientists create better diagnostic tools and treatments for future generations.

Risks: The main risks are minor discomfort from things like blood draws or skin irritation from the wearable devices. All personal information and data are kept private and secure.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • Novato, California, United States, 94945
        • Recruiting
        • Buck Institute
        • Contact:
        • Contact:
        • Principal Investigator:
          • Brianna Stubbs, Research Assistant Professor, PhD.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of healthy older adults aged 55 years or older.

Description

Inclusion Criteria:

  • Healthy adults aged 55 years or older.
  • Own a smartphone capable of running study-specific apps.
  • Willing and able to attend in-person visits at the Buck Institute in Novato, CA.
  • Reside in the Pacific or Mountain Time Zones.
  • Able to speak, read, and write English.
  • Willing to wear study devices continuously and allow researchers access to all data.
  • Able to provide informed consent.

Exclusion Criteria:

  • Hospitalization within the last 3 months.
  • Needing assistance with daily living activities.
  • Working night or irregular shifts.
  • Certain musculoskeletal, pulmonary, or cardiovascular conditions.
  • Uncontrolled high blood pressure (BP > 180/100 mmHg).
  • Bleeding disorders, anemia requiring treatment, or recent blood donation.
  • Poor vein access.
  • Unstable health conditions.
  • Chronic antibiotic use.
  • Certain psychiatric disorders.
  • Use of excluded medications, supplements, or products, including certain antibiotics or frequent sleep aids.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generation of a longitudinal multi-omic and digital health dataset characterizing biorhythms in older adults
Time Frame: 12 months
Establish a publicly shareable reference dataset integrating blood-based proteomic, metabolomic, and lipidomic profiles with continuous digital health data and microbiome samples from healthy older adults over time, capturing daily, weekly, and perturbation-induced physiological dynamics.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characterization of associations between molecular biomarkers and digital health data across time
Time Frame: 12 months
Identify and quantify temporal correlations between blood-derived molecular biomarkers and physiological signals collected via wearable devices, including responses to standardized challenges.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: James Yurkovich, PhD, Phenome Health, The Buck Institute for Research on Aging

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

July 30, 2025

First Submitted That Met QC Criteria

July 30, 2025

First Posted (Actual)

August 6, 2025

Study Record Updates

Last Update Posted (Estimated)

August 15, 2025

Last Update Submitted That Met QC Criteria

August 12, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • BUCK 2502
  • 1AY2AX000072-01 (Other Grant/Funding Number: ARPA-H)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health

Subscribe